| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 76.8 | ¤1,122,499 | US |
| JNJ | Johnson & Johnson | 54.7 | ¤619,296 | US |
| MRK | Merck & Co., Inc. | 54.3 | ¤317,051 | US |
| AZN | AstraZeneca PLC | 62.8 | ¤249,801 | GB |
| AMGN | Amgen Inc. | 67.8 | ¤218,501 | US |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| THC | Tenet Healthcare Corporation | 68.0 | ¤20,664 | US |
| STE | STERIS plc | 62.9 | ¤22,589 | IE |
| UTHR | United Therapeutics Corporation | 69.4 | ¤22,622 | US |
| DGX | Quest Diagnostics Incorporated | 60.2 | ¤26,324 | US |
| ALNY | Alnylam Pharmaceuticals, Inc | 68.4 | ¤28,919 | US |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| AMGN | Amgen Inc. | 67.8 | 32 | US |
| LLY | Eli Lilly and Company | 76.8 | 27 | US |
| PFE | Pfizer Inc. | 38.8 | 25 | US |
| DGX | Quest Diagnostics Incorporated | 60.2 | 23 | US |
| ZTS | Zoetis, Inc. Class A | 60.3 | 23 | US |
| BMY | Bristol-Myers Squibb Company | 67.6 | 22 | US |
| JNJ | Johnson & Johnson | 54.7 | 22 | US |
| RMD | ResMed Inc. | 66.6 | 20 | US |
| GILD | Gilead Sciences, Inc. | 51.3 | 19 | US |
| UTHR | United Therapeutics Corporation | 69.4 | 18 | US |
| Average Market Cap | ¤140,343 |
| Median Market Cap | ¤55,661 |
| Avg. 3 Mo. Dollar Vol. | ¤704,822,474 |
| Avg. 3 Mo. Trading Vol. | 5,131,279 |
| Last Rebalance Date | 03/23/2026 |
| Companies Replaced | 7 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 25.3 |
| Forward P/E Ratio (12 Mo.) | 18.9 |
| Price/Book Ratio | 5.6 |
| Avg. Revenue Chg. - 3 Yr | 22.6% |
| Avg. Op. Income Chg. - 3 Yr. | 33.9% |
| Avg. EPS Growth - 3 Yr. | 11.7% |
| Avg. EPS Growth - 1 Yr. | 12.1% |
| Avg. Operating Margin | 22.9% |
| Avg. LT Debt to Total Capital | 41.5% |
| Avg. Return on Equity | 22.0% |
| Dividend Yield | 0.5% |
| US Health Care Index | 60.34 |
| United States Of America | 90.0% |
| Switzerland | 3.33% |
| United Kingdom | 3.33% |
| Ireland | 3.33% |
